Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of August 2023. The report serves as a notification of transactions by persons discharging managerial responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory disclosure regarding a specific share transaction.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported activity is a share purchase by a Non-Executive Director.
Management Commentary and Unusual Items
Director Share Purchase:
- Person: Sally Johnson, Non-Executive Director.
- Date: 31 July 2023.
- Transaction: Purchase of 1,563 ordinary shares.
- Price: 632.2p (£6.322) per share.
- Total Value: £9,881.29.
- Venue: London Stock Exchange (XLON).
The filing contains no forward-looking guidance, risk updates, or management commentary beyond the transaction details.
Investor Verification Checklist
- Verify the current share price of Rentokil Initial plc to assess the timing of the director's purchase relative to market levels.
- Confirm the total shareholding of Sally Johnson post-transaction to understand her overall exposure.
- Review the company's most recent Form 20-F or interim financial report for actual revenue and profit metrics, as they are absent here.